These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25479771)

  • 1. Identification of potent inhibitors of the chicken soluble epoxide hydrolase.
    Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C
    Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
    Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
    Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
    Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.
    Morisseau C; Kodani SD; Kamita SG; Yang J; Lee KSS; Hammock BD
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
    Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
    J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
    Pecic S; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD; Zhu Z; Rinderspacher A; Deng SX
    Bioorg Med Chem Lett; 2013 Jan; 23(2):417-21. PubMed ID: 23237835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of potent inhibitors of the human microsomal epoxide hydrolase.
    Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD
    Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
    Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Newman JW; Wheelock CE; Dowdy DL; Hammock BD
    Biochem Pharmacol; 2002 May; 63(9):1599-608. PubMed ID: 12007563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
    Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
    Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
    Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
    Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.